# Rationale for PRD Distillation: prd-final.md

This document explains the rationale behind drafting `prd-final.md` by comparing it to the original `prd-1.md`, `prd-2.md`, and `prd-3.md`. The goal was to create a single, comprehensive, and clear Product Requirements Document that captures the best aspects of all three, resolving any ambiguities and ensuring a consistent vision for the "MediScout" project.

## Comparison and Rationale by Section:

### 1. Project Overview
*   **Originals:** `prd-1` and `prd-3` were similar, focusing on "Multi-agent AI Deep Researcher (Medical Domain Focus)" with a hackathon context. `prd-2` introduced the "MediScout" branding and provided a more detailed, aspirational summary with broader stakeholders.
*   **Rationale for Final:** I adopted the "MediScout" name from `prd-2` for a more distinct identity. The final version combines the comprehensive list of stakeholders from all three and integrates the detailed summary from `prd-2` while retaining the hackathon/MVP context from `prd-1` and `prd-3`.

### 2. Problem Statement
*   **Originals:** All three PRDs identified similar core problems: time-consuming manual research, fragmented information, and the overwhelming volume of medical literature.
*   **Rationale for Final:** I synthesized these points into a single, robust problem statement that emphasizes the manual, time-consuming, and fragmented nature of current research, the exponential growth of data, and the critical need for an automated, reproducible, and insightful solution.

### 3. Objectives & Success Criteria
*   **Originals:** `prd-1` focused on core automation, hypothesis generation, and hackathon-specific success criteria (e.g., demonstrable, single document + web). `prd-2` introduced more specific objectives (e.g., specific data sources, critical analysis, source citation) and KPIs (e.g., reduce review time, identify contradictions). `prd-3` added objectives related to agent implementation and explainable insights, with MVP success criteria (e.g., retrieval precision, insight quality).
*   **Rationale for Final:** I combined all unique objectives to form a comprehensive set. For success criteria, I merged the measurable, hackathon-focused criteria from `prd-1` and `prd-3` with the more detailed and KPI-driven criteria from `prd-2`, ensuring a balanced and actionable set for the MVP.

### 4. User Stories & Acceptance Criteria
*   **Originals:** `prd-1` provided generic, foundational user stories (Knowledge Base, Research Execution, Progress Monitoring, Report Consumption) with detailed acceptance criteria. `prd-2` offered more specific, persona-driven user stories (Clinical Researcher, Physician, Pharmaceutical Analyst) tied to particular medical use cases. `prd-3` introduced specific requirements like flagging contradictions and providing rationale for hypotheses.
*   **Rationale for Final:** I used the broader user story categories from `prd-1` as a framework and then integrated the specific scenarios, detailed requirements, and acceptance criteria from `prd-2` and `prd-3` into these categories, ensuring all user needs were covered.

### 5. Key Features & Requirements (Functional & Non-Functional)
*   **Originals:** All three PRDs outlined similar functional areas (document ingestion, data retrieval, analysis, report generation). `prd-2` was particularly strong in detailing the medical context and specific API integrations. `prd-3` emphasized explainability and local privacy.
*   **Rationale for Final:** I consolidated all functional requirements, detailing the capabilities of each agent and specifying the data sources and output formats. For non-functional requirements, I combined the UI/performance aspects from `prd-1` with the critical accuracy, verifiability, data privacy, and explainability from `prd-2` and `prd-3`.

### 6. User Flow / Process Diagram
*   **Originals:** `prd-1` and `prd-3` both presented clear, two-phase user flows (Setup/Upload and Research).
*   **Rationale for Final:** I adopted this consistent two-phase flow, detailing the steps involved in each phase for clarity.

### 7. Out of Scope
*   **Originals:** All three PRDs had similar lists of items that would not be part of the MVP (e.g., user accounts, polished UI, non-English support, medical advice).
*   **Rationale for Final:** I combined all unique out-of-scope items from the three PRDs into a single, comprehensive list to clearly define the boundaries of the MVP.

### 8. Dependencies & Risks
*   **Originals:** All three PRDs listed similar dependencies (APIs, LLM, Python libraries) and risks (API unreliability, LLM hallucination, integration complexity). `prd-2` and `prd-3` provided more specific mitigation strategies.
*   **Rationale for Final:** I consolidated all dependencies and risks, and crucially, included the detailed mitigation strategies from `prd-2` and `prd-3` to provide a more complete picture of potential challenges and how to address them.

### 9. Backlog
*   **Originals:** `prd-1` did not have an explicit backlog. `prd-2` listed future features (e.g., Zotero integration, full-text PDF analysis). `prd-3` provided a prioritized list of initial development tasks (e.g., examples, scaffolding, POCs).
*   **Rationale for Final:** I combined all backlog items, categorizing them as "Future Considerations/Prioritized Enhancements" to offer a comprehensive roadmap beyond the immediate MVP.

In essence, the `prd-final.md` aims to be a single source of truth, leveraging the strengths and details from each original PRD to create a more complete, coherent, and actionable document for the MediScout project.
